British Biotech Pharmaceuticals Ltd.
Records under this name other than patents British Biotech Pharmaceuticals Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to British Biotech Pharmaceuticals Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,386,883 | Computer-assisted education Formerly held Term ended Ended no later than Aug 7, 2019 · USPTO record | Term ended | Ended no later than Aug 7, 2019 | USPTO record |
| US 6,169,075 | Cytostatic agents Formerly held Term ended Term ended Sep 8, 2017 · USPTO record | Term ended | Term ended Sep 8, 2017 | USPTO record |
| US 6,790,834 | Cytostatic agents Formerly held Term ended Ended no later than Sep 8, 2017 · USPTO record | Term ended | Ended no later than Sep 8, 2017 | USPTO record |
| US 6,908,911 | Antibacterial agents Lapsed on the fee record Ended Jun 21, 2013 · USPTO record | Lapsed on the fee record | Ended Jun 21, 2013 | USPTO record |
| US 6,881,828 | Fusion proteins between antigenic amino acid sequences and beta-2-microglobulin Formerly held Lapsed on the fee record Ended Apr 19, 2013 · USPTO record | Lapsed on the fee record | Ended Apr 19, 2013 | USPTO record |
| US 6,846,825 | Antibacterial agents Lapsed on the fee record Ended Jan 25, 2013 · USPTO record | Lapsed on the fee record | Ended Jan 25, 2013 | USPTO record |
| US 6,787,522 | Antibacterial agents Lapsed on the fee record Ended Sep 7, 2012 · USPTO record | Lapsed on the fee record | Ended Sep 7, 2012 | USPTO record |
| US 6,716,878 | Antimicrobial agents Formerly held Lapsed on the fee record Ended Apr 6, 2012 · USPTO record | Lapsed on the fee record | Ended Apr 6, 2012 | USPTO record |
| US 7,323,448 | Antibacterial agents Lapsed on the fee record Ended Jan 29, 2012 · USPTO record | Lapsed on the fee record | Ended Jan 29, 2012 | USPTO record |
| US 7,323,563 | Hydroxamic acid derivatives as antibacterials Lapsed on the fee record Ended Jan 29, 2012 · USPTO record | Lapsed on the fee record | Ended Jan 29, 2012 | USPTO record |